On the other side, we failed to confirm the association between IDH1R132C mutation and reduced GPX4 levels reported by Wang et al. (21), but this might be explained by the different experimental conditions we worked under (cell lines versus ICC tissue and in vitro versus in vivo). This evidence concerns the gene GPX4 and intrahepatic cholangiocarcinoma.